All lobbying filings

AVENUE SOLUTIONS

Lobbying for MERCK & CO. INC. · developer, manufacturer and distributor of pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 2

Health Issues

Issues related to vaccines; Issues related to 340b

Medicare/Medicaid

Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.